IMRA

Q: What is the price of Imara (IMRA) today?

The current price of Imara (IMRA) is $ 17.05, representing a -35.16% gain over the past year. The stock began the year trading around $ 14.47 and is currently priced at $ 17.05. You can follow the real-time price chart, review historical performance, and track broader market trends directly on the platform.

Q: When does Imara (IMRA) pay dividends?

Imara (IMRA) distributed dividends in the last year,in the months of January, March, April and May totaling $ 1.08. The Dividend Yield for the last 12 months is 111.79%.

Q: Is Imara (IMRA) a good investment?

Imara (IMRA) is currently trading at $ 17.05 with a P/E ratio of 76.02. This represents a -93% premium compared to its historical average P/E. Over the past year, the stock has gained -35.16 and paid $ 1.08 in dividends, resulting in a dividend yield of 111.79%. The total shareholder return over the same period was -35.16%.Investors should keep in mind that past performance does not guarantee future results. This information is provided for educational purposes only and should not be considered investment advice.

Imara Inc.

Price

$ 17.05

return (12m)

-35.16%

p/e

76.02

p/bv

1.32

DIVIDEND YIELD

111.79%

IMRA price

Imara

If you had invested

exposure

years ago

7 days

30 days

6 months

YTD

1 year

5 years

10 years

15 years

ago, you would now have *

ago, you would now have:

*This calculation reflects price variation only.

Return on Investment IMRA

1 month

3 months

1 year

2 years

5 years

10 years

return

1 month

5.85%

3 months

22.80%

1 year

-35.16%

2 years

0.00%

5 years

21.03%

10 years

0.00%

Fundamentals IMRA

review the fundamentals of Imara shares

P/E

76.02

Sector: -1.95 Industry: 0.52

P/S (PSR)

Sector: 1.97 Industry: 2.45

P/BV

1.32

Sector: 2.12 Industry: 2.37

DIVIDEND YIELD (DY)

111.79%

Sector: - Industry: -

ROA

1.71%

Sector: -28.58% Industry: -27.25%

ROE

1.74%

Sector: -34.90% Industry: -37.73%

ROIC

-724.58%

Sector: -439.49% Industry: -94.70%

NET MARGIN

0.00%

Sector: -30.31% Industry: -32.17%

GROSS MARGIN

0.00%

Sector: 44.90% Industry: 49.66%

OPERATING MARGIN

0.00%

Sector: -25.22% Industry: -28.69%

EV/EBITDA

-3.54

Sector: -0.24 Industry: 0.86

EV/EBIT

-3.48

Sector: -1.89 Industry: -0.33

PRICE-TO-ASSETS

1.30

Sector: 1.16 Industry: 1.29

BVPS

12.88

Sector: 3.76 Industry: 4.82

EPS

0.22

Sector: -0.92 Industry: -0.75

EQUITY-TO-ASSETS RATIO

0.98

Sector: 0.43 Industry: 0.45

LIABILITIES / ASSETS

0.02

Sector: 0.46 Industry: 0.51

CAGR REVENUE 5 YEARS

0.00%

Sector: - Industry: -

CAGR PROFIT 5 YEARS

0.00%

Sector: - Industry: -

FAIR VALUE OF Imara ACCORDING TO BENJAMIN GRAHAM

Graham's Fair Value

The Fair Value formula was created by Benjamin Graham to identify stocks with appreciation potential or that are being traded for less than they are worth. Graham was one of the greatest investors in history and Warren Buffett’s mentor.

Current Price

$ 17.05

Fair Value

$ 7.98

Upside Return potential.

-53.17%

See Graham's ranking

Because it considers equity value in its calculation, this formula may not work well for technology companies.

This is not a buy/sell recommendation; the fair value calculation takes into account only the formula created by Benjamin Graham, published in the book The Intelligent Investor.

Fundamentals IMRA

DRAG THE FRAME TO SEE MORE DATA

Stock Comparison Tool

DRAG THE FRAME TO SEE MORE DATA

	p/e	p/bv	ROE	dy	market cap	net margin
LLY	40.12	32.50	81.02%	0.57%	$ 1.01 T	34.99%
ISRG	48.98	8.29	16.93%	0.00%	$ 145.93 B	28.15%
SNY	7.23	1.29	17.79%	3.99%	$ 108.01 B	14.75%
TMO	25.50	3.35	13.15%	0.38%	$ 174.59 B	15.15%
NVS	21.59	7.51	34.77%	2.03%	$ 292.21 B	23.92%
ABT	23.76	2.83	11.91%	2.85%	$ 149.12 B	13.91%
MDT	21.42	0.00	-%	3.54%	$ 102.82 B	13.20%
GSK	13.49	4.56	33.77%	3.33%	$ 105.82 B	17.79%
CVS	44.27	1.67	3.78%	2.61%	$ 129.80 B	0.72%
BSX	19.67	2.71	13.78%	0.00%	$ 70.13 B	17.29%
TMDX	14.42	5.02	34.80%	0.00%	$ 2.48 B	27.04%
IDXX	40.97	28.84	70.38%	0.00%	$ 44.87 B	24.63%
HCA	12.77	-29.12	-228.14%	0.76%	$ 86.73 B	8.89%
RMD	18.53	4.34	23.41%	0.93%	$ 28.16 B	27.44%
DHR	34.57	2.41	6.97%	0.76%	$ 127.51 B	14.89%
INMD	9.72	1.28	13.18%	0.00%	$ 847.35 M	23.27%
PHG	22.29	1.91	8.56%	3.83%	$ 25.19 B	5.50%
SYK	35.73	5.19	14.52%	1.11%	$ 119.24 B	13.21%
CI	12.12	1.87	15.39%	2.04%	$ 78.74 B	2.34%

Stock vs Indice Comparison Tool

If you had invested

years ago

2 years

5 years

10 years

ago, you would now have *

ago, you would now have:

*This calculation reflects price variation only.

IMRA Historical Dividends

current DY: 111.79%

5-year average DY: 111.79%

DRAG THE FRAME TO SEE MORE DATA

type	Ex - Dividend Date	payment date	value
Dividends	05/21/2026	05/27/2026	0,17100000
Dividends	04/23/2026	04/28/2026	0,14800000
Dividends	03/26/2026	03/31/2026	0,25000000
Dividends	02/26/2026	03/03/2026	0,30590000
Dividends	01/22/2026	01/27/2026	0,20800000
Dividends	12/25/2025	12/30/2025	1,41700000
Dividends	11/27/2025	12/02/2025	1,69400000
Dividends	10/23/2025	10/28/2025	3,01200000
Dividends	09/25/2025	09/30/2025	3,20000000
Dividends	08/21/2025	08/26/2025	2,90000000
Dividends	07/24/2025	07/29/2025	3,86500000
Dividends	06/26/2025	07/01/2025	1,89000000
Dividends	05/22/2025	05/28/2025	9,33000000

ABOUT Imara

Imara Inc.

Average Investor10 user rating

4.0 (4 people)

United States

10 years

Founded: 2016

2020

Time since IPO - 6 years

27

Employees

Imara Inc. (United States) is listed on the Nasdaq and has a market capitalization of $119.35 Millions, with shareholders equity totaling $90.13 Millions.

The company employs approximately 27 people and operates in the Health sector, within the Medical Supplies and Equipment industry.

Over the past 12 months, Imara Inc. reported $- in revenue, generating net income of $1.57 Million.

Key financial metrics include a P/E ratio of 76.02, a price-to-book (P/B) ratio of 1.32, and a trailing twelve-month dividend yield of 111.79%.

The company trades under the ticker IMRA.

Market cap

$ 119.35 Millions

Net worth

$ 90.13 Millions

$ 90,130,000.00

Assets

$ 91.96 Millions

$ 91,960,000.00

Total Shares Outstanding

7.00 Millions

7,000,000

Average Daily Trading Volume

$ 4.49 Thousand

$ 4,486.22

Sector

Health

Industry

Medical Supplies and Equipment

IMRA

IMRA revenue and profits

Financial Results IMRA

DRAG THE FRAME TO SEE MORE DATA

IMRA cash flow

DRAG THE FRAME TO SEE MORE DATA

Discover more stocks

CVS - CVS Health

$ 101.96 56,65% (12M)

P/E

44.27

2.61%

ROE

3.78%

P/BV

1.67

CI - Cigna

$ 298.00 --3,58% (12M)

P/E

12.12

2.04%

ROE

15.39%

P/BV

1.87

CNC - Centene

$ 65.19 18,06% (12M)

P/E

-4.98

0.00%

ROE

-29.93%

P/BV

1.49

HUM - Humana

$ 379.22 64,11% (12M)

P/E

40.27

0.93%

ROE

6.06%

P/BV

2.44

SNY - Sanofi

$ 44.25 --7,40% (12M)

P/E

7.23

3.99%

ROE

17.79%

P/BV

1.29

LLY - Eli Lilly

$ 1,133.00 41,29% (12M)

P/E

40.12

0.57%

ROE

81.02%

P/BV

32.50

HCA - HCA Healthcare

$ 387.18 5,20% (12M)

P/E

12.77

0.76%

ROE

-228.14%

P/BV

-29.12

NVS - Novartis

$ 153.07 30,64% (12M)

P/E

21.59

2.03%

ROE

34.77%

P/BV

7.51

CVS - CVS Health

$ 101.96 56,65% (12 M)

P/L

44.27

2.61%

ROE

3.78%

P/VP

1.67

CI - Cigna

$ 298.00 --3,58% (12 M)

P/L

12.12

2.04%

ROE

15.39%

P/VP

1.87

CNC - Centene

$ 65.19 18,06% (12 M)

P/L

-4.98

0.00%

ROE

-29.93%

P/VP

1.49

HUM - Humana

$ 379.22 64,11% (12 M)

P/L

40.27

0.93%

ROE

6.06%

P/VP

2.44

SNY - Sanofi

$ 44.25 --7,40% (12 M)

P/L

7.23

3.99%

ROE

17.79%

P/VP

1.29

LLY - Eli Lilly

$ 1,133.00 41,29% (12 M)

P/L

40.12

0.57%

ROE

81.02%

P/VP

32.50

HCA - HCA Healthcare

$ 387.18 5,20% (12 M)

P/L

12.77

0.76%

ROE

-228.14%

P/VP

-29.12

NVS - Novartis

$ 153.07 30,64% (12 M)

P/L

21.59

2.03%

ROE

34.77%

P/VP

7.51

Frequently Asked Questions

What is the price of Imara (IMRA) today?

The current price of Imara (IMRA) is $ 17.05, representing a -35.16% gain over the past year. The stock began the year trading around $ 14.47 and is currently priced at $ 17.05. You can follow the real-time price chart, review historical performance, and track broader market trends directly on the platform.

When does Imara (IMRA) pay dividends?

Imara (IMRA) distributed dividends in the last year,in the months of January, March, April and May totaling $ 1.08. The Dividend Yield for the last 12 months is 111.79%.

Is Imara (IMRA) a good investment?

Imara (IMRA) is currently trading at $ 17.05 with a P/E ratio of 76.02. This represents a -93% premium compared to its historical average P/E. Over the past year, the stock has gained -35.16 and paid $ 1.08 in dividends, resulting in a dividend yield of 111.79%. The total shareholder return over the same period was -35.16%.

Investors should keep in mind that past performance does not guarantee future results. This information is provided for educational purposes only and should not be considered investment advice.

How can I buy Imara (IMRA) stock?

You can buy Imara (IMRA) shares through any brokerage account that provides access to U.S. stock exchanges. After opening and funding your account, simply search for the ticker symbol IMRA and place a buy order. Before investing, consider factors such as your financial goals, risk tolerance, and overall portfolio allocation.

How much would 100 shares of Imara (IMRA) yield today?

Over the past month, Imara (IMRA) has returned 5.85% — -35.16% over the past year, and 21.03% over the past five years, including price appreciation and dividends.

In the last 12 months, the company paid a total of 19.06 per share in dividends, resulting in a dividend yield of 111.79%.

If you were to purchase 100 shares of Imara (IMRA) today at the current price of $ 17.05 your total investment would be $ 1,705.00.

Based on historical performance, the investment would have grown to approximately:

$ 1,105.52 after 1 year
$ 2,063.56 after 5 years
$ 1,705.00 after 10 years

Past performance does not guarantee future results. This content is for informational purposes only and should not be considered investment advice.

IMRA

Imara Inc.

Price

return (12m)

p/e

p/bv

DIVIDEND YIELD

Return on Investment IMRA

review the fundamentals of Imara shares

P/E

P/S (PSR)

P/BV

DIVIDEND YIELD (DY)

ROA

ROE

ROIC

NET MARGIN

GROSS MARGIN

OPERATING MARGIN

EV/EBITDA

EV/EBIT

PRICE-TO-ASSETS

BVPS

EPS

EQUITY-TO-ASSETS RATIO

LIABILITIES / ASSETS

CAGR REVENUE 5 YEARS

CAGR PROFIT 5 YEARS

Graham's Fair Value

current DY: 111.79%

5-year average DY: 111.79%

type

Ex - Dividend Date

payment date

value

ABOUT Imara

Imara Inc.

United States

10 years

2020

27

PROFIT X PRICE IMRA

Financial Results IMRA

IMRA cash flow

Asset, Revenue and Profit Growth - IMRA

IMRA balance sheet

CVS - CVS Health

CI - Cigna

CNC - Centene

HUM - Humana

SNY - Sanofi

LLY - Eli Lilly

HCA - HCA Healthcare

NVS - Novartis

CVS - CVS Health

CI - Cigna

CNC - Centene

HUM - Humana

SNY - Sanofi

LLY - Eli Lilly

HCA - HCA Healthcare

NVS - Novartis

Frequently Asked Questions